Table 1.
Treatment | Control | Rh2(H2cit)4 | Magh-Rh2(H2cit)4 | Magh-citrate |
---|---|---|---|---|
Hematology parameters |
|
|
|
|
WBC (/mm3) |
18445.50± 6020.68 |
24555.00 ± 9693.69 |
45774.00 ± 11995.51 |
59060.00 ± 25390.07 |
RBC (x109/mm3) |
8.69±0.27B |
10.82± 1.19 |
10.07 ± 1.03 |
10.17 ± 0.86 |
HGB (g/dL) |
13.60±0.42 |
14.75 ± 0.33 |
14.26 ± 0.14 |
13.36 ± 0.85 |
HCT (%) |
41.60±1.38 |
44.62 ± 0.96 |
44.40 ± 0.39 |
41.09 ± 2.51 |
Lymphocytes (%) |
28.75±6.65 |
38.50 ± 13.88 |
10.80± 3.35 |
18.71 ± 7.66 |
Rods (%) |
1.25±1.25 |
0.50 ± 0.50 |
0.00 ± 0.00 |
1.43 ± 0.65 |
Segmented(%) |
67.00±7.14 |
57.67 ± 13.40 |
84.00 ± 3.36 |
70.57 ± 7.40 |
Eosinophils (%) |
0.00±0.00 |
0.00 ± 0.00 |
0.00 ± 0.00 |
0.14 ± 0.14 |
Basophils (%) |
0.25±0.25 |
0.17 ± 0.17 |
0.00 ± 0.00 |
0.14 ± 0.14 |
Monocytes (%) |
2.75±0.75 |
3.17 ± 1.01 |
5.20 ± 1.11 |
9.00 ± 4.94 |
Biochemical parameters |
25.20±6.22 |
25.50 ± 3.57 |
20.86 ± 2.15 |
21.33 ± 3.38 |
ALT (U/L) |
0.10±0.00 |
0.10 ± 0.00 |
0.10 ± 0.00 |
0.13 ± 0.02 |
Creatinine (mg/dL) |
125.60±18.59 |
143.67 ± 14.22 |
127.57 ± 12.10 |
112.33 ± 15.23 |
Serum Fe (mg/dL) |
Legend: WBC (White Blood Cells); RBC (Red Blood Cells); HGB (Hemoglobin); HCT (Hematocrit); ALT (alanine transaminase).
1Values are represented as mean ± standard error.
Note: all treatments have no statistical difference when compared with untreated control mice (P>0.05).b.